Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of Repaglinide”

Showing 4 of 0 results

Early research (Phase 1)Study completedNCT06503679
What this trial is testing

A Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy Participants

Who this might be right for
Healthy
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 49
Early research (Phase 1)UnknownNCT04664725
What this trial is testing

Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion

Who this might be right for
Prostate Cancer Patients
Jiangsu HengRui Medicine Co., Ltd. 18
Early research (Phase 1)Study completedNCT01780051
What this trial is testing

A Pharmacokinetic Study to Compare Co-administration of Repaglinide and Metformin HCl to Administration of Combination Preparation of Those Two Components

Who this might be right for
Diabetes Mellitus, Type 2
Dalim BioTech Co., Ltd. 48
Early research (Phase 1)Study completedNCT01536366
What this trial is testing

Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 27

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation